UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

AR-Regulated TWEAK-FN14 Pathway Promotes Prostate Cancer Bone Metastasis

Cancer research (Chicago, Ill.), 2014-08, Vol.74 (16), p.4306-4317

2014

Volltextzugriff (PDF)

Androgen Receptor Splice Variants Determine Taxane Sensitivity in Prostate Cancer

Cancer research (Chicago, Ill.), 2014-04, Vol.74 (8), p.2270-2282

2014

Volltextzugriff (PDF)

Role of Reduced-Intensity Conditioning Allogeneic Hematopoietic Stem-Cell Transplantation in Older Patients With De Novo Myelodysplastic Syndromes: An International Collaborative Decision Analysis

Journal of clinical oncology, 2013-07, Vol.31 (21), p.2662-2670

2013

Volltextzugriff (PDF)

A Phase I Combination Study of Olaparib with Cisplatin and Gemcitabine in Adults with Solid Tumors

Clinical cancer research, 2012-04, Vol.18 (8), p.2344-2351

2012

Volltextzugriff (PDF)

Impaired postural stability as a marker of premanifest Huntington's disease

Movement disorders, 2010-10, Vol.25 (14), p.2428-2433

2010

Volltextzugriff (PDF)

Low dose, alternating electric current inhibits growth of prostate cancer

The Prostate, 2010-04, Vol.70 (5), p.529-539

2010

Volltextzugriff (PDF)

The expression of osteoclastogenesis-associated factors and osteoblast response to osteolytic prostate cancer cells

The Prostate, 2010-03, Vol.70 (4), p.412-424

2010

Volltextzugriff (PDF)

Nemo-like kinase induces apoptosis and inhibits androgen receptor signaling in prostate cancer cells

The Prostate, 2009-10, Vol.69 (14), p.1481-1492

2009

Volltextzugriff (PDF)

RAD001 (Everolimus) inhibits growth of prostate cancer in the bone and the inhibitory effects are increased by combination with docetaxel and zoledronic acid

The Prostate, 2008-06, Vol.68 (8), p.861-871

2008

Volltextzugriff (PDF)

Impairments in source memory for olfactory and visual stimuli in preclinical and clinical stages of Huntington's disease

Journal of clinical and experimental neuropsychology, 2007-05, Vol.29 (4), p.395-404

2007

Volltextzugriff (PDF)

Basic Mechanisms Responsible for Osteolytic and Osteoblastic Bone Metastases

Clinical cancer research, 2006-10, Vol.12 (20), p.6213s-6216s

2006

Volltextzugriff (PDF)

Targeting Factors Involved in Bone Remodeling as Treatment Strategies in Prostate Cancer Bone Metastasis

Clinical cancer research, 2006-10, Vol.12 (20), p.6285s-6290s

2006

Volltextzugriff (PDF)

Targeted chemotherapy with cytotoxic bombesin analogue AN‐215 inhibits growth of experimental human prostate cancers

International journal of cancer, 2006-01, Vol.118 (1), p.222-229

2006

Volltextzugriff (PDF)

Osteoprotegerin in prostate cancer bone metastasis

Cancer research (Chicago, Ill.), 2005-03, Vol.65 (5), p.1710-1718

2005

Volltextzugriff (PDF)

Metastases of prostate cancer express estrogen receptor-beta

Urology (Ridgewood, N.J.), 2004-10, Vol.64 (4), p.814-820

2004

Volltextzugriff (PDF)

Characterization of C4–2 Prostate Cancer Bone Metastases and Their Response to Castration

Journal of bone and mineral research, 2003-10, Vol.18 (10), p.1882-1888

2003

Volltextzugriff (PDF)

A novel method of generating prostate cancer metastases from orthotopic implants

The Prostate, 2003-07, Vol.56 (2), p.110-114

2003

Volltextzugriff (PDF)

Prostate cancer expression of runt-domain transcription factor Runx2, a key regulator of osteoblast differentiation and function

The Prostate, 2003-06, Vol.56 (1), p.13-22

2003

Volltextzugriff (PDF)

LuCaP 35: A new model of prostate cancer progression to androgen independence

The Prostate, 2003-06, Vol.55 (4), p.239-246

2003

Volltextzugriff (PDF)

Expression of the human cachexia‐associated protein (HCAP) in prostate cancer and in a prostate cancer animal model of cachexia

International journal of cancer, 2003-05, Vol.105 (1), p.123-129

2003

Volltextzugriff (PDF)

Elevation of cytokine levels in cachectic patients with prostate carcinoma

Cancer, 2003-03, Vol.97 (5), p.1211-1216

2003

Volltextzugriff (PDF)

Zoledronic Acid Exhibits Inhibitory Effects on Osteoblastic and Osteolytic Metastases of Prostate Cancer

Clinical cancer research, 2003-01, Vol.9 (1), p.295-306

2003

Volltextzugriff (PDF)

Establishment and characterization of osseous prostate cancer models: Intra-tibial injection of human prostate cancer cells

The Prostate, 2002-06, Vol.52 (1), p.20-33

2002

Volltextzugriff (PDF)

Inhibition of Androgen-independent Growth of Prostate Cancer Xenografts by 17β-Estradiol

Clinical cancer research, 2002-04, Vol.8 (4), p.1003-1007

2002

Volltextzugriff (PDF)

Serum Osteoprotegerin Levels Are Increased in Patients with Advanced Prostate Cancer

Clinical cancer research, 2001-10, Vol.7 (10), p.2977-2983

2001

Volltextzugriff (PDF)

1 – 25 von 37

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieAmerican Heart Journal

ThemaBiological And Medical Sciences

ThemaLife Sciences & Biomedicine

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(37)
Mit Volltextzugriff
(36)

Publikationsform

Artikel
(37)

Sprache

Englisch
(37)

Erscheinungsjahr

n.n

Thema

13 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

AR-Regulated TWEAK-FN14 Pathway Promotes Prostate Cancer Bone Metastasis

Androgen Receptor Splice Variants Determine Taxane Sensitivity in Prostate Cancer

Role of Reduced-Intensity Conditioning Allogeneic Hematopoietic Stem-Cell Transplantation in Older Patients With De Novo Myelodysplastic Syndromes: An International Collaborative Decision Analysis

A Phase I Combination Study of Olaparib with Cisplatin and Gemcitabine in Adults with Solid Tumors

Impaired postural stability as a marker of premanifest Huntington's disease

Low dose, alternating electric current inhibits growth of prostate cancer

The expression of osteoclastogenesis-associated factors and osteoblast response to osteolytic prostate cancer cells

Nemo-like kinase induces apoptosis and inhibits androgen receptor signaling in prostate cancer cells

RAD001 (Everolimus) inhibits growth of prostate cancer in the bone and the inhibitory effects are increased by combination with docetaxel and zoledronic acid

Impairments in source memory for olfactory and visual stimuli in preclinical and clinical stages of Huntington's disease

Basic Mechanisms Responsible for Osteolytic and Osteoblastic Bone Metastases

Targeting Factors Involved in Bone Remodeling as Treatment Strategies in Prostate Cancer Bone Metastasis

Targeted chemotherapy with cytotoxic bombesin analogue AN‐215 inhibits growth of experimental human prostate cancers

Osteoprotegerin in prostate cancer bone metastasis

Metastases of prostate cancer express estrogen receptor-beta

Characterization of C4–2 Prostate Cancer Bone Metastases and Their Response to Castration

A novel method of generating prostate cancer metastases from orthotopic implants

Prostate cancer expression of runt-domain transcription factor Runx2, a key regulator of osteoblast differentiation and function

LuCaP 35: A new model of prostate cancer progression to androgen independence

Expression of the human cachexia‐associated protein (HCAP) in prostate cancer and in a prostate cancer animal model of cachexia

Elevation of cytokine levels in cachectic patients with prostate carcinoma

Zoledronic Acid Exhibits Inhibitory Effects on Osteoblastic and Osteolytic Metastases of Prostate Cancer

Establishment and characterization of osseous prostate cancer models: Intra-tibial injection of human prostate cancer cells

Inhibition of Androgen-independent Growth of Prostate Cancer Xenografts by 17β-Estradiol

Serum Osteoprotegerin Levels Are Increased in Patients with Advanced Prostate Cancer

Aktive Filter

Suchergebnisse filtern